AIMS/HYPOTHESIS: We assessed country-level and individual-level patterns in patient and provider perceptions of diabetes care. METHODS: The study used a cross-sectional design with face-to-face or telephone interviews of diabetic patients and healthcare providers in 13 countries from Asia, Australia, Europe and North America. Participants were randomly selected adults with type 1 or type 2 diabetes (n=5,104), and randomly selected diabetes-care providers, including primary-care physicians (n=2,070), diabetes specialist physicians (n=635) and nurses (n=1,122). Multivariate analysis was used to examine the relationships between outcomes and both country and respondent characteristics, and the interaction between these two factors. RESULTS: Providers rated chronic-care systems and remuneration for chronic care as mediocre. Patients reported that ease of access to care was high, but not without financial barriers. Patients reported moderate levels of collaboration among providers, and providers indicated that several specialist disciplines were not readily available to them. Patients reported high levels of collaboration with providers in their own care. Provider endorsement of primary prevention strategies for type 2 diabetes was high. Patients with fewer socio-economic resources and more diabetes complications had lower access (and/or higher barriers) to care and lower quality of patient-provider collaboration. Countries differed significantly for all outcomes, and the relationships between respondent characteristics and outcomes varied by country. CONCLUSIONS/ INTERPRETATION: There is much need for improvement in applying the chronic-care model to the treatment and prevention of diabetes in all of the countries studied. Each country must develop its own priorities for improving diabetes care and comparison with other countries can help identify strengths as well as weaknesses.
AIMS/HYPOTHESIS: We assessed country-level and individual-level patterns in patient and provider perceptions of diabetes care. METHODS: The study used a cross-sectional design with face-to-face or telephone interviews of diabeticpatients and healthcare providers in 13 countries from Asia, Australia, Europe and North America. Participants were randomly selected adults with type 1 or type 2 diabetes (n=5,104), and randomly selected diabetes-care providers, including primary-care physicians (n=2,070), diabetes specialist physicians (n=635) and nurses (n=1,122). Multivariate analysis was used to examine the relationships between outcomes and both country and respondent characteristics, and the interaction between these two factors. RESULTS: Providers rated chronic-care systems and remuneration for chronic care as mediocre. Patients reported that ease of access to care was high, but not without financial barriers. Patients reported moderate levels of collaboration among providers, and providers indicated that several specialist disciplines were not readily available to them. Patients reported high levels of collaboration with providers in their own care. Provider endorsement of primary prevention strategies for type 2 diabetes was high. Patients with fewer socio-economic resources and more diabetes complications had lower access (and/or higher barriers) to care and lower quality of patient-provider collaboration. Countries differed significantly for all outcomes, and the relationships between respondent characteristics and outcomes varied by country. CONCLUSIONS/ INTERPRETATION: There is much need for improvement in applying the chronic-care model to the treatment and prevention of diabetes in all of the countries studied. Each country must develop its own priorities for improving diabetes care and comparison with other countries can help identify strengths as well as weaknesses.
Authors: Jako S Burgers; Julia V Bailey; Niek S Klazinga; Akke K Van Der Bij; Richard Grol; Gene Feder Journal: Diabetes Care Date: 2002-11 Impact factor: 19.112
Authors: Anton J Kuzel; Steven H Woolf; Valerie J Gilchrist; John D Engel; Thomas A LaVeist; Charles Vincent; Richard M Frankel Journal: Ann Fam Med Date: 2004 Jul-Aug Impact factor: 5.166
Authors: Janice Wiley; Mary Westbrook; Janet Long; Jerry R Greenfield; Richard O Day; Jeffrey Braithwaite Journal: Health Expect Date: 2013-12-18 Impact factor: 3.377
Authors: A Lapolla; G Di Cianni; A Di Benedetto; I Franzetti; A Napoli; L Sciacca; E Torlone; L Tonutti; E Vitacolonna; D Mannino Journal: Int J Endocrinol Date: 2012-04-26 Impact factor: 3.257
Authors: Nira Roopnarinesingh; Nancyellen Brennan; Claude Khan; Paul W Ladenson; Felicia Hill-Briggs; Rita Rastogi Kalyani Journal: BMC Health Serv Res Date: 2015-09-19 Impact factor: 2.655
Authors: Emily B Schroeder; Jay Desai; Julie A Schmittdiel; Andrea R Paolino; Jennifer L Schneider; Glenn K Goodrich; Jean M Lawrence; Katherine M Newton; Gregory A Nichols; Patrick J O'Connor; Marcy Fitz-Randolph; John F Steiner Journal: Interact J Med Res Date: 2015-06-30
Authors: Qingqing Lou; Yufeng Chen; Xiaohui Guo; Li Yuan; Tao Chen; Chun Wang; Li Shen; Zilin Sun; Fang Zhao; Xia Dai; Jin Huang; Huiying Yang Journal: PLoS One Date: 2014-05-06 Impact factor: 3.240